The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
Evelien Moorkens, B. Godman, I. Huys, Iris Hoxha +39 more
2020Frontiers in Pharmacology67 citations Open access
Semantic Scholar

